Clustermarket Joins the Tetra Partner Network to Help Customers Maximize and Manage Lab Utilization and Operations

BOSTON, Mass. --  TetraScience, Inc., the R&D Data Cloud company, today announced a partnership with Clustermarket, the leading provider of unique lab management software, to help customers expand their ability to create scientific and laboratory management efficiencies. “Scientific laboratories are challenged to maximize productivity and return on investment,” said Alan Millar, Ph.D., Vice President of [...]

Oxford Nanopore technology update: CTO Clive G Brown unveils latest sequencing chemistry with highest performance to date, Short Fragment Mode and latest methylation performance evaluations

Clive G Brown, CTO, Oxford Nanopore Technologies, reviews some of the latest technology updates during a webinar today. Highlights include performance and base modification calling improvements, as well as updates on the recently-released Short Fragment Mode (SFM) and a new basecaller.  Summary:  Latest chemistry enables 99.3% raw read accuracy at high data yields; new Kit [...]

Cytosurge launches cell line engineering services based on proprietary FluidFM® technology

Cytosurge, a global leader in precision single cell manipulation, today announced the launch of FluidFM® CellEDIT, a CRISPR cell line engineering service based on its FluidFM® technology.   Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for [...]

Promega to Launch Post-Doctoral Research Program to Develop New Tools for Genome Editing

MADISON, Wis. -- Life science researchers can explore new ideas for genome engineering technology through a newly announced post-doctoral research program launched by Promega with mentoring support from AstraZeneca. The program gives researchers the unique opportunity to work on groundbreaking projects in an emerging field while collaborating with scientists at a global pharmaceutical company and [...]

Bruker Introduces Ultima Investigator Plus — Multiphoton Microscope for Tissue Imaging

Larger Field-of-View and Deep Imaging for In Vivo Neuroscience and Immuno-Oncology Research MADISON, Wisconsin – Bruker today announced the release of the Ultima Investigator Plus, the newest modular platform addition to the industry-leading Ultima line of multiphoton microscopes for deep tissue fluorescence imaging. With an expanded field of view, optimized optics for two- and three-photon imaging, [...]

IPA Announces Agreement to Acquire BioStrand BV – Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence

VICTORIA, British Columbia -- IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) is pleased to announce that it has entered into a definitive share purchase agreement (SPA) to acquire, through its wholly-owned subsidiary ImmunoPrecise Netherlands BV, control over BioStrand BV, BioKey BV, and BioClue BV (hereinafter collectively referred to as “ BioStrand ”), [...]

Quanterix Receives Funding From The Alzheimer’s Drug Discovery Foundation To Accelerate Alzheimer’s Disease Diagnostic Plasma Test Development

Funding will power a series of prospective clinical trials to validate Quanterix’ multi-analyte test in collaboration with Amsterdam University Medical Centers (Amsterdam UMC) Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has partnered with the Alzheimer’s Drug Discovery Foundation (ADDF) to accelerate [...]

BioEngine Raises Another RMB 200 Million, Continues to Promote the “Made in China” Serum-Free Culture Media

Recently, China's leading company in animal cell culture technology and domestic serum-free culture media, Shanghai BioEngine Sci-Tech Co., LTD, announced the completion of a 200 million RMB Series B++ financing round. The financing was led by Legend Capital, followed by Addor Capital and Tsing Song Capital, and the old shareholder Hankang Capital continued to increase [...]

Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global

Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a Director Candidate Recommended by Caligan, if Casdin and Viking Transaction Closes Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting SOUTH SAN [...]

Absolute Antibody Licenses Novel Fc Silencing Technology from mAbsolve

Fully silent Fc-engineered antibodies accessible for therapeutic antibody development Redcar and Oxford, UK: Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, and mAbsolve, developers of a novel Fc silencing variant, today announced a licensing deal for mAbsolve’s Fc silencing technology. The agreement provides Absolute Antibody clients with easy license-free access to the new [...]

Access IBO on Knowledge Center